List of Tables
Table 1. Global CGRP Antagonists Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global CGRP Antagonists Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global CGRP Antagonists Market Competitive Situation by Manufacturers in 2024
Table 4. Global CGRP Antagonists Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global CGRP Antagonists Sales Market Share by Manufacturers (2020-2025)
Table 6. Global CGRP Antagonists Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global CGRP Antagonists Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market CGRP Antagonists Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of CGRP Antagonists, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of CGRP Antagonists, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of CGRP Antagonists, Product Type & Application
Table 12. Global Key Manufacturers of CGRP Antagonists, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global CGRP Antagonists by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CGRP Antagonists as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global CGRP Antagonists Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global CGRP Antagonists Sales by Region (2020-2025) & (K Units)
Table 18. Global CGRP Antagonists Sales Market Share by Region (2020-2025)
Table 19. Global CGRP Antagonists Sales by Region (2026-2031) & (K Units)
Table 20. Global CGRP Antagonists Sales Market Share by Region (2026-2031)
Table 21. Global CGRP Antagonists Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global CGRP Antagonists Revenue Market Share by Region (2020-2025)
Table 23. Global CGRP Antagonists Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global CGRP Antagonists Revenue Market Share by Region (2026-2031)
Table 25. North America CGRP Antagonists Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America CGRP Antagonists Sales by Country (2020-2025) & (K Units)
Table 27. North America CGRP Antagonists Sales by Country (2026-2031) & (K Units)
Table 28. North America CGRP Antagonists Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America CGRP Antagonists Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe CGRP Antagonists Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe CGRP Antagonists Sales by Country (2020-2025) & (K Units)
Table 32. Europe CGRP Antagonists Sales by Country (2026-2031) & (K Units)
Table 33. Europe CGRP Antagonists Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe CGRP Antagonists Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific CGRP Antagonists Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific CGRP Antagonists Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific CGRP Antagonists Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific CGRP Antagonists Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific CGRP Antagonists Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America CGRP Antagonists Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America CGRP Antagonists Sales by Country (2020-2025) & (K Units)
Table 42. Latin America CGRP Antagonists Sales by Country (2026-2031) & (K Units)
Table 43. Latin America CGRP Antagonists Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America CGRP Antagonists Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa CGRP Antagonists Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa CGRP Antagonists Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa CGRP Antagonists Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa CGRP Antagonists Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa CGRP Antagonists Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global CGRP Antagonists Sales (K Units) by Type (2020-2025)
Table 51. Global CGRP Antagonists Sales (K Units) by Type (2026-2031)
Table 52. Global CGRP Antagonists Sales Market Share by Type (2020-2025)
Table 53. Global CGRP Antagonists Sales Market Share by Type (2026-2031)
Table 54. Global CGRP Antagonists Revenue (US$ Million) by Type (2020-2025)
Table 55. Global CGRP Antagonists Revenue (US$ Million) by Type (2026-2031)
Table 56. Global CGRP Antagonists Revenue Market Share by Type (2020-2025)
Table 57. Global CGRP Antagonists Revenue Market Share by Type (2026-2031)
Table 58. Global CGRP Antagonists Price (US$/Unit) by Type (2020-2025)
Table 59. Global CGRP Antagonists Price (US$/Unit) by Type (2026-2031)
Table 60. Global CGRP Antagonists Sales (K Units) by Application (2020-2025)
Table 61. Global CGRP Antagonists Sales (K Units) by Application (2026-2031)
Table 62. Global CGRP Antagonists Sales Market Share by Application (2020-2025)
Table 63. Global CGRP Antagonists Sales Market Share by Application (2026-2031)
Table 64. Global CGRP Antagonists Revenue (US$ Million) by Application (2020-2025)
Table 65. Global CGRP Antagonists Revenue (US$ Million) by Application (2026-2031)
Table 66. Global CGRP Antagonists Revenue Market Share by Application (2020-2025)
Table 67. Global CGRP Antagonists Revenue Market Share by Application (2026-2031)
Table 68. Global CGRP Antagonists Price (US$/Unit) by Application (2020-2025)
Table 69. Global CGRP Antagonists Price (US$/Unit) by Application (2026-2031)
Table 70. PFIZER INC(Biohaven) Company Information
Table 71. PFIZER INC(Biohaven) Description and Business Overview
Table 72. PFIZER INC(Biohaven) CGRP Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. PFIZER INC(Biohaven) CGRP Antagonists Product
Table 74. PFIZER INC(Biohaven) Recent Developments/Updates
Table 75. ABBVIE INC Company Information
Table 76. ABBVIE INC Description and Business Overview
Table 77. ABBVIE INC CGRP Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. ABBVIE INC CGRP Antagonists Product
Table 79. ABBVIE INC Recent Developments/Updates
Table 80. Amgen Company Information
Table 81. Amgen Description and Business Overview
Table 82. Amgen CGRP Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Amgen CGRP Antagonists Product
Table 84. Amgen Recent Developments/Updates
Table 85. Teva Company Information
Table 86. Teva Description and Business Overview
Table 87. Teva CGRP Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Teva CGRP Antagonists Product
Table 89. Teva Recent Developments/Updates
Table 90. Eli Lilly and Company Company Information
Table 91. Eli Lilly and Company Description and Business Overview
Table 92. Eli Lilly and Company CGRP Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Eli Lilly and Company CGRP Antagonists Product
Table 94. Eli Lilly and Company Recent Developments/Updates
Table 95. Lundbeck Company Information
Table 96. Lundbeck Description and Business Overview
Table 97. Lundbeck CGRP Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Lundbeck CGRP Antagonists Product
Table 99. Lundbeck Recent Developments/Updates
Table 100. Novartis Company Information
Table 101. Novartis Description and Business Overview
Table 102. Novartis CGRP Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Novartis CGRP Antagonists Product
Table 104. Novartis Recent Developments/Updates
Table 105. Key Raw Materials Lists
Table 106. Raw Materials Key Suppliers Lists
Table 107. CGRP Antagonists Distributors List
Table 108. CGRP Antagonists Customers List
Table 109. CGRP Antagonists Market Trends
Table 110. CGRP Antagonists Market Drivers
Table 111. CGRP Antagonists Market Challenges
Table 112. CGRP Antagonists Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
Table 116. Authors List of This Report
List of Figures
Figure 1. Product Picture of CGRP Antagonists
Figure 2. Global CGRP Antagonists Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global CGRP Antagonists Market Share by Type: 2024 & 2031
Figure 4. Monoclonal Antibodies Product Picture
Figure 5. CGRP Receptor Inhibitor Product Picture
Figure 6. Global CGRP Antagonists Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global CGRP Antagonists Market Share by Application: 2024 & 2031
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Other
Figure 11. Global CGRP Antagonists Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global CGRP Antagonists Market Size (2020-2031) & (US$ Million)
Figure 13. Global CGRP Antagonists Sales (2020-2031) & (K Units)
Figure 14. Global CGRP Antagonists Average Price (US$/Unit) & (2020-2031)
Figure 15. CGRP Antagonists Report Years Considered
Figure 16. CGRP Antagonists Sales Share by Manufacturers in 2024
Figure 17. Global CGRP Antagonists Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest CGRP Antagonists Players: Market Share by Revenue in CGRP Antagonists in 2024
Figure 19. CGRP Antagonists Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global CGRP Antagonists Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America CGRP Antagonists Sales Market Share by Country (2020-2031)
Figure 22. North America CGRP Antagonists Revenue Market Share by Country (2020-2031)
Figure 23. United States CGRP Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada CGRP Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe CGRP Antagonists Sales Market Share by Country (2020-2031)
Figure 26. Europe CGRP Antagonists Revenue Market Share by Country (2020-2031)
Figure 27. Germany CGRP Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France CGRP Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. CGRP Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy CGRP Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia CGRP Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific CGRP Antagonists Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific CGRP Antagonists Revenue Market Share by Region (2020-2031)
Figure 34. China CGRP Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan CGRP Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea CGRP Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India CGRP Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia CGRP Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan CGRP Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Southeast Asia CGRP Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Latin America CGRP Antagonists Sales Market Share by Country (2020-2031)
Figure 42. Latin America CGRP Antagonists Revenue Market Share by Country (2020-2031)
Figure 43. Mexico CGRP Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Brazil CGRP Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Argentina CGRP Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Middle East and Africa CGRP Antagonists Sales Market Share by Country (2020-2031)
Figure 47. Middle East and Africa CGRP Antagonists Revenue Market Share by Country (2020-2031)
Figure 48. Turkey CGRP Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia CGRP Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. UAE CGRP Antagonists Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Global Sales Market Share of CGRP Antagonists by Type (2020-2031)
Figure 52. Global Revenue Market Share of CGRP Antagonists by Type (2020-2031)
Figure 53. Global CGRP Antagonists Price (US$/Unit) by Type (2020-2031)
Figure 54. Global Sales Market Share of CGRP Antagonists by Application (2020-2031)
Figure 55. Global Revenue Market Share of CGRP Antagonists by Application (2020-2031)
Figure 56. Global CGRP Antagonists Price (US$/Unit) by Application (2020-2031)
Figure 57. CGRP Antagonists Value Chain
Figure 58. Channels of Distribution (Direct Vs Distribution)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
